Gian‐Andrea Thanei

Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials

Amit Bar‐Or, Gian‐Andrea Thanei, Christopher Harp et al. · EBioMedicine · 2023 · 80 citations · Full text

Development of an age‐adjusted model for blood neurofilament light chain

Christopher Harp, Gian‐Andrea Thanei, Xiaoming Jia et al. · Annals of Clinical and Translational Neurology · 2022 · 40 citations · Full text

Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Ali A. Habib, Chongbo Zhao, Inmaculada Aban et al. · The Lancet Neurology · 2025 · 25 citations · Full text

Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS

João Cerqueira, Achim Berthele, Bruce Cree et al. · Neurology · 2025 · 16 citations · Full text